Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Stanford University, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Stanford University, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Stanford University, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Stanford University, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 9 | 1 |
| Stanford University, Medical Devices Deals, 2010 to YTD 2016 | 10 | 1 |
| Stanford University, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 11 | 3 |
| Stanford University, Pharmaceuticals &Healthcare, Deal Details | 14 | 35 |
| Venture Financing | 14 | 1 |
| Arcus Biosciences Raises USD70 Million in Venture Financing | 14 | 2 |
| Partnerships | 16 | 1 |
| RedHill Biopharma Enters into Research Agreement with Stanford University School of Medicine | 16 | 1 |
| twoXAR Enters into Agreement with Stanford University School of Medicine | 17 | 1 |
| twoXAR Enters into Research Agreement with Stanford University | 18 | 1 |
| Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center | 19 | 1 |
| SRI Biosciences Enters into Agreement with Stanford Cancer Institute | 20 | 1 |
| ImmunoCellular Therapeutics Enters into Research Agreement with Stanford University | 21 | 1 |
| SRI Biosciences Enters into Agreement with Stanford Cancer Institute | 22 | 1 |
| aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery | 23 | 2 |
| Activaero Enters Into Research Agreement With Stanford University | 25 | 1 |
| Benitec Biopharma Enters Into An Agreement With Stanford University | 26 | 1 |
| Sanofi-aventis Enters Into Research Collaboration With Bio-X Stanford University | 27 | 1 |
| Salinas Valley Memorial Healthcare Forms Joint Venture With Stanford Hospital &Clinics | 28 | 1 |
| VLife Sciences Technologies Enters Into Agreement With NCBS, Stanford University And Technical University Of Denmark | 29 | 2 |
| Licensing Agreements | 31 | 1 |
| Forty Seven Enters into Licensing Agreement with Stanford University | 31 | 1 |
| Medgenics Enters into Licensing Agreement with Stanford University | 32 | 1 |
| Eiger BioPharma Enters into Licensing Agreement with Stanford University for Post-Bariatric Surgical Hypoglycemia | 33 | 1 |
| Eiger BioPharma Enters into Licensing Agreement with Stanford University | 34 | 1 |
| Eiger BioPharma Enters into Licensing Agreement with Stanford University for Pulmonary Arterial Hypertension | 35 | 1 |
| Abeona Therapeutics Enters into Licensing Agreement with Stanford University | 36 | 1 |
| Horizon Discovery Enters into Licensing Agreement with Stanford University | 37 | 1 |
| Neurotrope Enters into Licensing Agreement with Stanford University | 38 | 1 |
| Globavir Enters into Licensing Agreement with Stanford University | 39 | 1 |
| Quest PharmaTech Enters Into Licensing Agreement With Stanford University For Anti-MUC1 IgE Technology | 40 | 1 |
| Personalis Enters Into Licensing Agreement With Stanford University | 41 | 1 |
| Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology | 42 | 1 |
| Stem Cell Theranostics Enters into Agreement with Stanford University | 43 | 1 |
| Transparency Life Sciences Enters Into Option Licensing Agreement With Stanford University | 44 | 1 |
| SiteOne Therapeutics Enters into Licensing Agreement with Stanford University | 45 | 1 |
| AIDS Research Enters Into Licensing Agreement With Stanford University | 46 | 1 |
| Acquisition | 47 | 1 |
| Stanford Health Care Acquires ValleyCare Health | 47 | 1 |
| Stanford Hospital Acquires CareCounsel Health Advocacy Specialist | 48 | 1 |
| Stanford University - Key Competitors | 49 | 1 |
| Key Employees | 50 | 1 |
| Locations And Subsidiaries | 51 | 2 |
| Head Office | 51 | 1 |
| Other Locations &Subsidiaries | 51 | 2 |
| Appendix | 53 | 1 |
| Methodology | 53 | 1 |
| About GlobalData | 53 | 1 |
| Contact Us | 53 | 1 |
| Disclaimer | 53 | 1 |